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Excess levels of circulating amino acids (AAs) play
a causal role in specific human pathologies, including
obesity and type 2 diabetes. Moreover, obesity and
diabetes are contributing factors in the development
of cancer,with recent studies suggesting that this link
is mediated in part by AA activation of mammalian
target of rapamycin (mTOR) Complex 1. AAs appear
to mediate this response through class III phosphati-
dylinositol 3-kinase (PI3K), or human vacuolar protein
sorting 34 (hVps34), rather than through the canonical
class I PI3K pathway used by growth factors and hor-
mones. Here we show that AAs induce a rise in intra-
cellular Ca2+ ([Ca2+]i), which triggers mTOR Complex
1 and hVps34 activation. We demonstrate that the
rise in [Ca2+]i increases the direct binding of Ca
2+/
calmodulin (CaM) to an evolutionarily conserved
motif in hVps34 that is required for lipid kinaseactivity
and increased mTOR Complex 1 signaling. These
findings have important implications regarding
the basic signaling mechanisms linking metabolic
disorders with cancer progression.
INTRODUCTION
Nutrient overload is a key contributing factor to the obesity epi-
demic (Um et al., 2006), which until recently was largely confined
to theWesternworld but now is aworldwide problem (Finkelstein
et al., 2005). The morbidity of obesity not only extends to diabe-
tes and cardiovascular disease but recently has been shown to
be linked to 20% of cancer deaths (Calle and Kaaks, 2004). A
critical effector of nutrient signaling is the mammalian target of
rapamycin (mTOR) protein kinase, which exists in two distinct
complexes (Wullschleger et al., 2006). The first, mTOR Complex
1, is sensitive to rapamycin and includes three additional pro-
teins: regulatory-associated protein of mTOR (raptor), G protein
b subunit-like protein (GbL), and proline-rich PKB/Akt substrate
40 kDa (PRAS40) (Dann et al., 2007; Kim et al., 2002). In contrast,
mTOR Complex 2 is rapamycin insensitive and consists in addi-
tion to GbL of rapamycin-insensitive companion of mTOR456 Cell Metabolism 7, 456–465, May 2008 ª2008 Elsevier Inc.(rictor), mammalian stress-activated protein kinase (SAPK)-inter-
acting protein 1 (mSin1), and protein observed with rictor (protor)
(Dann et al., 2007; Pearce et al., 2007). Both complexes are reg-
ulated by hormones and growth factors; however, only mTOR
Complex 1 is acutely regulated by nutrients, such as amino acids
(AAs) and glucose (Dann et al., 2007). The importance of the AA
arm of mTOR Complex 1 signaling is highlighted by the observa-
tion that circulating AAs, particularly branched-chain AAs
(BCAAs), are elevated in obese humans and are known to drive
mTOR Complex 1 signaling (Krebs, 2005; Um et al., 2006).
AA activation of mTOR Complex 1 increases growth through
increased ribosome biogenesis and elevated rates of protein
synthesis, while suppressing autophagy (Wullschleger et al.,
2006). However, mTOR Complex 1 also acts as a homeostatic
regulator to attenuate insulin-induced uptake of nutrients under
conditions of nutrient overload (Patti and Kahn, 2004; Tremblay
et al., 2005a; Tzatsos and Kandror, 2006). These effects are at-
tributed in part to mTOR Complex 1 phosphorylation of insulin
receptor substrate 1 (IRS1) at sites that antagonize binding of
IRS1 to either the insulin receptor or class I phosphatidylinositol
3-kinase (PI3K), attenuating insulin action (Tzatsos and Kandror,
2006; Um et al., 2004).Moreover, recent studies have shown that
AAs can directly mediate these responses by phosphorylation of
IRS1 by S6 kinase 1 (S6K1) at specific sites residing at the amino
(Harrington et al., 2004) and carboxyl (Tremblay et al., 2007) ter-
mini of IRS1, respectively. These observations have stimulated
the need to elucidate the molecular mechanisms by which nutri-
ent overload, through increased mTOR Complex 1 activation,
leads to the development of specific pathologies.
Hormones and growth factors mediate mTOR Complex 1
activation through a canonical signaling cascade triggered by
the activation of class I PI3K and protein kinase B (PKB), leading
to the sequential activation of the small GTPase Ras homolog
enriched in brain (Rheb) and mTOR Complex 1 (Dann et al.,
2007). In contrast, AAs stimulate mTOR Complex 1 activation
through class III PI3K, or human vacuolar protein sorting 34
(hVps34) (Byfield et al., 2005; Nobukuni et al., 2005). AA-induced
activation of hVps34 leads to increased production of phospha-
tidylinositol 3-phosphate (PI(3)P), which acts to recruit Fab1/
YOTB/-2K632.12/Vac1/EEA1 (FYVE) or PI(3)P-targeting phox
homology (PX) domain-containing proteins to early endosomes
(Nobukuni et al., 2007). These PI(3)P-rich domain protein com-
plexes are known to function as intracellular signaling platforms
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hVps34 protein levels or ectopic expression of a FYVE domain
construct, which sequesters PI(3)P, blunts AA-induced mTOR
Complex 1 signaling (Byfield et al., 2005; Nobukuni et al.,
2005). In contrast, lowering hVps34 protein levels has no effect
on insulin-induced PKB/Akt activation (Byfield et al., 2005;
Nobukuni et al., 2005). However, despite the importance of AA
signaling in controllingmTORComplex 1 signaling, little is known
of the underlying mechanism that mediates the hVps34
response.
Here we set out to identify the pathway and mechanism by
which AAs signal to hVps34 to stimulate mTOR Complex 1 sig-
naling. Unexpectedly, we found that AAs induce an increase in
intracellular Ca2+ ([Ca2+]i), leading to enhanced binding of cal-
modulin (CaM) to hVps34, an interaction that occurs through
an evolutionarily conserved CaM-binding site, leading to the
activation of mTOR Complex 1 signaling.
RESULTS
AA-Induced mTOR Complex 1 Signaling
is [Ca2+]i Dependent
Although, like growth factors and hormones, AAs induce mTOR
Complex 1-mediated S6K1 activation, they do not activate PKB,
as judged by PKB Ser473 phosphorylation (Byfield et al., 2005;
Hara et al., 1998; Nobukuni et al., 2005). Consistent with these
findings, we observed no effect of AAs on either PKB Ser473
Figure 1. Ca2+ Chelators Selectively Block
mTOR Complex 1 Signaling
(A) HeLa cells were transfected with 16 nM PKBa
siRNA for 48 hr (see Experimental Procedures).
After serum withdrawal overnight, cells were de-
prived of amino acids (AAs) for 2 hr and then stim-
ulated with double the concentration of AAs pres-
ent in DMEM for 30 min (left panel). Alternatively,
after transfection, cells were deprived of serum
overnight followed by stimulation with 200 nM in-
sulin for 30 min (right panel).
(B) HeLa cells were treated with AAs (left panel) or
insulin (middle panel) as described in (A). Prior to
stimulation, cells were pretreated with 2 mM
BAPTA-AM for 15 min where indicated. Quantifi-
cation of western blots from three independent
experiments (right panel) was performed using
ImageQuant TL software (Amersham). Data are
presented as mean ± SD.
(C) HeLa cells were treated with AAs as in (A).
Where indicated, cells were pretreated with either
2 mM EGTA or 2 mM BAPTA-AM for 15 min (left
panel). S6K1 siRNA (16 nM) transfection and AA
stimulation (right panel) were performed as in (A).
or Thr308 phosphorylation (Figure 1A;
see also Figure S1A available online).
Moreover, siRNA depletion of PKBa, the
major PKB isoform present in HeLa cells,
had no impact on AA-induced S6K1
Thr389 phosphorylation but, like AA with-
drawal (Nobukuni et al., 2005), inhibited
the insulin-induced response (Figure 1A).
In addition, the extracellular signal-regulated kinases (Erks),
which have been implicated in regulating mTOR Complex 1
activation through phosphorylation of tuberous sclerosis protein
2 (TSC2) (Um et al., 2006), were not affected by AA stimulation
(Figure S1B). Like AAs, agents that increase [Ca2+]i levels have
been reported to induce S6K1 activation without inducing PKB
activation (Conus et al., 1998), raising the possibility that AA
induction of S6K1 is dependent on [Ca2+]i levels. To assess this
possibility, AA-deprived HeLa cells were stimulated by the read-
dition of AAs in the absence or presence of the [Ca2+]i chelator
BAPTA-acetoxymethyl ester (BAPTA-AM). We found that readdi-
tion of AAs led to increased S6K1 Thr389 phosphorylation, a re-
sponse attenuated by BAPTA-AM (Figure 1B). Moreover,
BAPTA-AM suppressed insulin-induced S6K1 Thr389 phos-
phorylation but had no effect on PKB Ser473 phosphorylation,
the phosphorylation of the PKB substrates TSC2 Ser939 and
FoxO1 Thr24, or Erk Thr202 and Tyr204 phosphorylation
(Figure 1B and Figures S1C and S1D, respectively). Importantly,
pretreatment of AA-deprived cells with the cell-impermeant
Ca2+ chelator ethylene glycol tetra-acetic acid (EGTA) also
suppressed AA induction of S6K1 Thr389 phosphorylation
(Figure 1C, left panel), indicating that extracellular Ca2+ is also re-
quired for this response. In addition, these effects appeared to be
mTOR Complex 1 dependent, as EGTA and BAPTA-AM blocked
4E binding protein 1 (4E-BP1) Ser65 phosphorylation (Figure 1C,
left panel), a known mTOR Complex 1 substrate (Gingras et al.,
1999). Finally, earlier studies had shown that leucine-inducedCell Metabolism 7, 456–465, May 2008 ª2008 Elsevier Inc. 457
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(A) Confocal fluorescence images of Fluo-4-stained HeLa cells treated with AAs as in Figure 1A for 5 min in the absence or presence of BAPTA-AM.
(B) Intracellular Ca2+ ([Ca2+]i) traces in Fura-2-loaded HeLa cells stimulated with AAs as in Figure 1A. First panel shows representative single-cell [Ca
2+]i response
to AAs followed by addition of 0.5 mM histamine. Second panel shows effect of removing extracellular Ca2+ by replacement of medium with AA-containing buffer
without added Ca2+. Third panel shows effect of AA withdrawal on single-cell [Ca2+]i response; this experiment was carried out in the presence of 10% dialyzed
FCS. Fourth panel shows effect of extracellular Ca2+ chelation with 4 mM EGTA followed by treatment with 2 mM thapsigargin (Tg).
(C) Left panel: HeLa cells plated onto 35 mm tissue culture plates were deprived of serum and AAs, then loaded with calcium green-1/AM, and [Ca2+]i responses
were monitored by confocal microscopy before and after addition of 150 mM Tg. The trace is the mean Tg-evoked [Ca2+]i increase (n = 332 cells). Right panel:
HeLa cells were treated with AAs as in Figure 1A and then treated with 150 mMTg for 30min in the absence or presence of either 2 mMEGTA or 2 mMBAPTA-AM.
EGTA and BAPTA-AM were added 15 min prior to the addition of Tg.
(D) HeLa cells treated with either EGTA or BAPTA-AMwere stimulated with AAs or Tg for 15min as described in Figure 1A and Figure 2C, respectively. Cells were
harvested and lysed, mTOR was immunoprecipitated, and in vitro mTOR Complex 1 activity was assayed as described previously (Sancak et al., 2007).GSK3b phosphorylation is sensitive to rapamycin and PKB inde-
pendent (Peyrollier et al., 2000), and more recently it has been
argued that GSK3b Ser9 phosphorylation and c-Myc stability
are mediated by S6K1 in TSC2-deficient cells (Zhang et al.,
2006). Consistent with these results, we found that AA-induced
GSK3b Ser9 phosphorylation and c-Myc stability are sup-
pressed by EGTA and BAPTA-AM (Figure 1C, right panel). More-
over, the effects of these Ca2+ chelators appear to be mediated
by inhibition of S6K1, as siRNA depletion of S6K1 attenuated
both responses (Figure 1C). These results suggest that both
AA- and insulin-induced mTOR Complex 1 signaling require
[Ca2+]i.
AAs Induce an Increase in [Ca2+]i
To discriminate between a permissive role for Ca2+ in mTOR
Complex 1 signaling versus an AA-induced increase in [Ca2+]i,
cells were loaded with the Ca2+-sensitive indicator dye Fluo-4,458 Cell Metabolism 7, 456–465, May 2008 ª2008 Elsevier Inc.and [Ca2+]i levels were monitored by fluorescence microscopy
(Thomas et al., 1996). The addition of AAs evoked a rapid in-
crease in [Ca2+]i, which was largely inhibited by preincubation
with BAPTA-AM (Figure 2A). Oscillations of [Ca2+]i are a common
formof physiological Ca2+ signaling, and transition to a sustained
[Ca2+]i rise is typical of maximal stimulation (Thomas et al., 1996).
AA-evoked [Ca2+]i increases, detected by employing Fura-2, in-
cluded both [Ca2+]i oscillations (159/304 cells) and sustained
[Ca2+]i increases (145/304 cells) (Figure 2B, first and second
panels, respectively). A submaximal dose of the IP3-linked ago-
nist histamine also evoked [Ca2+]i oscillations, albeit with a higher
amplitude and frequency compared with the AA-induced [Ca2+]i
responses (Figure 2B, first panel). The [Ca2+]i response to AAs
was rapidly reversed by AA withdrawal (Figure 2B, third panel)
or by either removal of extracellular Ca2+ or addition of EGTA
(Figure 2B, second and fourth panels, respectively). In the
presence of EGTA, addition of the endoplasmic reticulum (ER)
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caused a rapid increase in [Ca2+]i, indicating that EGTA treat-
ment had not depleted internal Ca2+ stores (Figure 2B, fourth
panel). This suggests that the AA-induced [Ca2+]i signal requires
entry of extracellular Ca2+. Other studies have shown the impor-
tance of the BCAA leucine in inducing mTOR Complex 1 signal-
ing, as compared with other essential AAs, such as phenylala-
nine, or other BCAAs, such as isoleucine (Hara et al., 1998).
Consistent with earlier observations (Hara et al., 1998), we found
that leucine, but not phenylalanine or isoleucine, evoked a signif-
icant increase in S6K1 Thr389 phosphorylation and [Ca2+]i
(Figure S2A) and that this response was reversed by removal
of leucine (Figure S2B and data not shown). Thus, AAs, and
leucine alone, induce an increase in [Ca2+]i, which is dependent
on the influx of extracellular Ca2+.
A Rise in [Ca2+]i Is Sufficient for mTOR
Complex 1 Activation
To determine whether a rise in [Ca2+]i is sufficient to recapitulate
AA-induced S6K1 Thr389 phosphorylation, AA-deprived cells
were treated with Tg in the presence of external Ca2+. The results
showed that such treatment leads to a sustained increase in
[Ca2+]i (Figure 2C) and in S6K1 Thr389 as well as 4E-BP1
Ser65 phosphorylation (Figure 2C), whereas Tg had no effect
on Erk or PKB phosphorylation (Figure S1B). Consistent with
the transient nature of the Tg-induced rise in [Ca2+]i in the pres-
ence of EGTA (Figure 2B, fourth panel), the increase in S6K1
Thr389 and 4E-BP1 Ser65 phosphorylation was blocked by pre-
treatment of cells with EGTA, as well as with BAPTA-AM
(Figure 2C). In addition, Tg alone did not increase the uptake of
AAs, including leucine (Figure S2C). Recent studies have shown
that immunoprecipitates of mTOR Complex 1 from insulin-stim-
ulated cells have increased in vitro kinase activity toward S6K1
and 4E-BP1 (Sancak et al., 2007). Following similar assay condi-
tions, we found that immunoprecipitates of mTOR from AA-stim-
ulated cells, versus AA-deprived cells, had increased in vitro
mTOR Complex 1 kinase activity toward S6K1 and 4E-BP1 as
substrates (Figure 2D; Figure S2C). Moreover, the effect of AAs
on the in vitro mTOR Complex 1 kinase activity could be recapit-
ulated by Tg and blocked by either EGTA or BAPTA-AM
(Figure 2D; Figure S2D). Consistent with the rise in [Ca2+]i trigger-
ing increased mTOR Complex 1 kinase signaling, neither rapa-
mycin nor wortmannin blocked the AA-induced rise in [Ca2+]i
(data not shown). These data strongly support a model whereby
the AA-induced increase in [Ca2+]i leads to mTOR Complex 1
activation.
AA Activation of hVps34 Is Mediated by [Ca2+]i
To determine where [Ca2+]i acts in the mTOR Complex 1 path-
way, we first examined whether Tg activation of S6K1 in the
absence of AAs is sensitive to wortmannin. The results showed
that Tg-induced S6K1 Thr389 phosphorylation was abolished
by pretreatment with wortmannin (Figure 3A), similar to results
observed with AAs (Figure 3A). Moreover, as might be expected
from the apparently distinct mechanisms by which Tg and AAs
induce increased [Ca2+]i, the two together caused an apparent
additive increase in S6K1 Thr389 phosphorylation (Figure 3A).
We also found that siRNA depletion of Rheb protein levels
blocked Tg-induced S6K1 Thr389 phosphorylation (Figure 3B),as we previously reported for the AA response (Nobukuni
et al., 2005). Consistent with these effects being mediated by
hVps34, depletion of the lipid kinase with a previously described
siRNA (Nobukuni et al., 2005) also attenuated Tg-induced S6K1
Thr389 phosphorylation (Figure 3B). To determine whether the
effects of increased [Ca2+]i on mTOR Complex 1 activation are
mediated through hVps34, we analyzed the effect of BAPTA-
AM on PI(3)P production and hVps34 activation as described
previously (Byfield et al., 2005; Nobukuni et al., 2005). The results
showed that preloading AA-deprived cells with BAPTA-AM was
as effective as wortmannin in blocking the increase in AA-in-
duced PI(3)P production (Figure 3C). Consistent with this finding,
preincubation of AA-deprived cells with BAPTA-AM blocked AA-
stimulated hVps34 activation (Figure 3D) as scored for in an
immunocomplex activity assay (Byfield et al., 2005). Moreover,
removal of leucine, which leads to a drop in both S6K1 Thr389
phosphorylation (data not shown) and [Ca2+]i (Figures S2A and
S2B), inhibits hVps34 activity to the same extent as total AAwith-
drawal (Figure S3A). These findings support a model whereby
Ca2+ mediates increased mTOR Complex 1 signaling by regulat-
ing hVps34 activity.
CaM Is Required for mTOR Complex 1 Activation
Recently it was reported that Ca2+, through CaM, regulates
hVps34 activity during bacterial infection of macrophages by
Mycobacterium tuberculosis (Vergne et al., 2003). To test the
potential role of Ca2+/CaM in AA-induced mTOR Complex 1
signaling, we pretreated cells with N-(6-aminohexyl)-5-chloro-
1-naphthalenesulfonamide (W7), a cell-permeable CaM antago-
nist that binds to CaM, thus preventing the binding of Ca2+/CaM
to target enzymes (Kahl andMeans, 2003). Consistent with a role
for CaM in the Ca2+ response, pretreatment of HeLa cells with
W7 blocked the ability of AAs to induce S6K1 Thr389 phosphor-
ylation (Figure 4A). To test this model further, we asked whether
depletion of CaM has an impact on AA-induced mTOR Complex
1 signaling. There are three distinct CaM genes, each encoding
the identical CaMprotein (Means et al., 1982). Treatment of HeLa
cells with a mixture of three distinct siRNAs, each specific for
a single CaM gene product, resulted in depleted levels of CaM
and inhibition of AA-induced S6K1 Thr389 phosphorylation
(Figure 4B). In parallel, hVps34 immunoprecipitated from such
cells exhibited reduced phosphatidylinositol 3-OH (PtdIns)
kinase activity in vitro (Figure 4B). In contrast, treatment with
a nonsilencing siRNA had no effect on either response (Fig-
ure 4B). To test whether Ca2+ affects the ability of CaM to interact
with hVps34, cells were lysed in the presence of amild detergent,
3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate
(CHAPS), and in the absence of Ca2+. The lysate was then incu-
bated with CaM-linked agarose beads in the presence of either
Ca2+ or EGTA. The beads were washed twice in binding buffer
containing either Ca2+ or EGTA, and Ca2+-dependent interacting
proteins were released by extensive washes of both sets of
beads in EGTA. The results showed that the beads initially
incubated with Ca2+, in contrast to those incubated with EGTA,
specifically bound hVps34 (Figure 4C). As we have previously
noted (Nobukuni et al., 2005), immunoprecipitates of endoge-
nous mTOR also contain hVps34 (Figure S3B). Here we found
that CaM-agarose beads also bound mTOR in a Ca2+-depen-
dent manner (Figure 4C). Moreover, this interaction wasCell Metabolism 7, 456–465, May 2008 ª2008 Elsevier Inc. 459
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(A) HeLa cells, pretreated with either DMSO or 100 nM wortmannin for 15 min, were stimulated with AAs or Tg as in Figure 2C.
(B) HeLa cells were transfected with either 16 nM Rheb or hVps34 siRNA as in Figure 1A and then treated with 150 mM Tg for 30 min as in Figure 2C where
indicated. Western blot analysis was conducted using the indicated antibodies (see Experimental Procedures).
(C) HeLa cells were treated with AAs as in Figure 1A and preincubated for 15 min with either 2 mM BAPTA-AM or 100 nM wortmannin where indicated. Immu-
nostaining with PI(3)P antibody was carried out as described previously (Nobukuni et al., 2005). Quantification of immunostaining from four independent exper-
iments (right panel) was performed as in Figure 1B. Data are presented as mean ± SD.
(D) 293T cells were deprived of AAs and then stimulated with AAs as described previously (Byfield et al., 2005; Nobukuni et al., 2005) in either the absence or
the presence of BAPTA-AM, as in Figure 1B. hVps34 activity assay was performed on hVps34 immunoprecipitated from the same amount of protein extract
(see Experimental Procedures). Note: the differential radioactivity at the origins is due to contaminating radioactive beads from the interphase (see Experimental
Procedures). Quantification of autoradiograms from three independent experiments (right panel) was performed as in Figure 1B. Data are presented as
mean ± SD.dependent on hVps34, as siRNA depletion of hVps34 protein
blocked the ability of CaM-agarose beads to interact with
mTOR (Figure 4C). However, the hVps34-mTOR interaction ap-
pears to be both Ca2+ and AA independent, as the same amount
of hVps34 coimmunoprecipitated with endogenous mTOR in the
presence of Ca2+ or EGTA and in the absence or presence of AAs
(Figure 4C; Figure S3B). These results support a model whereby
the effects of Ca2+ on mTOR Complex 1 signaling are mediated
by Ca2+/CaM via hVps34 (see Discussion).460 Cell Metabolism 7, 456–465, May 2008 ª2008 Elsevier Inc.Ca2+/CaM Binds to hVps34
To identify potential Ca2+/CaM target proteins in the mTOR
Complex 1 signaling pathway, we queried the Calmodulin Target
Database (http://calcium.uhnres.utoronto.ca/ctdb/). Most CaM
targets contain one of two recognition motifs: a Ca2+-dependent
motif, or a Ca2+-independent modified version of an IQ motif
(Rhoads and Friedberg, 1997). Analysis of hVps34 itself revealed
a potential Ca2+-dependent CaM-binding motif between resi-
dues 318 and 334, in the PI3K accessory domain (Nobukuni
Cell Metabolism
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To test whether CaM interacts directly with hVps34, we resolved
immunoprecipitated GST-hVps34 by SDS-PAGE and deter-
mined by far western analysis whether it interacted with CaM
(Hall, 2004). The results showed that CaM bound directly to
GST-hVps34 in the presence of Ca2+, but not EGTA (Figure 5B).
Moreover, this interaction was independent of AA stimulation
(Figure 5B), suggesting that AA-induced posttranslational modi-
fications of hVps34 are not required for Ca2+/CaM binding.
These findings raised the possibility that the AA-induced rise in
[Ca2+]i acts to stabilize binding of the Ca
2+/CaM complex to
hVps34, as suggested for the binding of the Ca2+/CaM complex
to type II Ca2+/CaM-dependent protein kinase (Meyer et al.,
1992). Consistent with this prediction, employing a cell-perme-
able bifunctional protein-protein crosslinking agent, we found
an approximately 2- to 3-fold increase in the amount of CaM
bound to hVps34 following AA stimulation, which was blocked
by pretreatment with W7 (Figure 5C). Thus, the AA-induced
rise in [Ca2+]i appears to stabilize an interaction between CaM
and hVps34.
Ca2+/CaM Is Required for hVps34 Activity
To elucidate the role of Ca2+/CaM in hVps34 activation, we took
advantage of a GST epitope-tagged hVps34 construct, which
we previously showed by ectopic expression drives Thr389
phosphorylation of a Myc-tagged S6K1 reporter, but only in the
presence of AAs (Nobukuni et al., 2005). Consistent with these
findings, we observed that when immunoprecipitated from cells
in the presence of AAs, this construct displayed high hVps34
activity, which was sharply reduced by AA or leucine withdrawal
as well as incubation in the presence of BAPTA-AM (Figure
S4A). To determine whether the Ca2+/CaM-hVps34 interaction
is mediated through the presumed Ca2+/CaM-binding motif,
we generated two GST epitope-tagged hVps34 mutants,
Phe318Arg and Leu330Arg/Leu334Arg (see Figure 5A). The
mutants, as well as GST-tagged wild-type (WT) and kinase-
dead (KD) hVps34, were expressed at comparable levels, but
only WT and KDGST-hVps34 interacted strongly with CaM-aga-
rose beads in the presence of Ca2+ (Figure 6A; Figure S4B).
Furthermore, like the KD GST-hVps34, both mutants were inac-
tive in vitro when compared to WT GST-hVps34 (Figure 6B). The
absence of lipid kinase activity in the Ca2+/CaM-binding mutants
did not appear to be attributable simply to protein misfolding, as
the ability of hVps34 mutants to bind to the known hVps34-inter-
acting proteins hVps15 and beclin (Nobukuni et al., 2007) was
unaffected (Figure S4C). In agreement with these findings, coex-
pression of the Ca2+/CaM-binding motif mutants or KD GST-
hVps34 with Myc-tagged GST-S6K1, in contrast to WT GST-
hVps34, suppressed S6K1 reporter Thr389 phosphorylation,
suggesting that all three mutants acted dominant-negatively
(Figure 6C). These findings imply that hVps34 requires Ca2+/
CaM for production of PI(3)P. Compatible with this hypothesis,
extensive washes with EGTA and/or W7, as compared to exten-
sive washes in the presence of Ca2+, removed Ca2+/CaM from
immunoprecipitated endogenous hVps34 (Figure S4D) and
significantly reduced hVps34 in vitro lipid kinase activity
(Figure 6D). Importantly, readdition of Ca2+/CaM restored PI3K
activity, an effect abolished by the presence of W7 (Figure 6D).
These findings show that hVps34 activity is modulated by
Ca2+/CaM and that AAs appear to induce hVps34 activation by
increasing [Ca2+]i levels.
DISCUSSION
The role of AAs inmTORComplex 1 signaling was initially uncov-
ered in studies on AA inhibition of autophagy, which revealed
that AAs in parallel induce an increase in S6K1 activation
(Dann et al., 2007). With the identification of mTOR Complex 1,
it was found that AAs and glucose, but not growth factors, cause
a conformational change in mTOR Complex 1, which through
raptor allows mTOR to access and phosphorylate S6K1 (Kim
et al., 2002). Consistent with such a model, it was subsequently
found that the ability of Rheb to interact with mTORComplex 1 is
inhibited in the absence of AAs (Long et al., 2005). This led to the
Figure 4. CaM Is Required for hVps34
Activity and mTOR Complex 1 Signaling
(A) HeLa cells were treated with AAs as in
Figure 1A in the absence or presence of 10 mM
W7. W7 was added 15 min prior to AA stimulation.
(B) HeLa cells were transfected with either 45 nM
nonsilencing (NS) siRNA or a siRNAmix containing
15 nM each of CaM1, CaM2, and CaM3 siRNA, as
in Figure 1A (see Experimental Procedures). Fol-
lowing transfection, cells were treated with AAs
as in Figure 1A. hVps34 activity assay was per-
formed on hVps34 immunoprecipitated as de-
scribed in Experimental Procedures.
(C) HeLa cells were treated with AAs as in
Figure 1A. Extracts were prepared in the absence
of Ca2+ and then divided into two aliquots, with
one brought to 0.5 mM CaCl2 and the other to
2 mM EGTA. CaM-agarose beads were added to
each aliquot of extract, and binding assays were
performed as described previously (Vergne et al.,
2003). Right: endogenousmTORwas immunopre-
cipitated from cells in the presence of either 2 mM
EGTA or 0.5 mM CaCl2.Cell Metabolism 7, 456–465, May 2008 ª2008 Elsevier Inc. 461
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Complex 1, potentially releasing an inhibitor and allowing Rheb
to interact with and activate mTOR Complex 1 (Long et al.,
2005). Recent studies have revealed a potential inhibitor,
FKBP38, which binds to the FKBP12-rapamycin binding site
on mTOR Complex 1 and is released by AA treatment and
interaction with Rheb-GTP (Bai et al., 2007; Figure 7).
The data presented here are consistent with the model above.
Here we show that AAs induce an increase in [Ca2+]i, which acts
to enhance the binding of Ca2+/CaM to hVps34, resulting in in-
creased PI(3)P levels and enhanced mTOR Complex 1 signaling.
We have previously demonstrated that activation of S6K1 is as-
sociated with a Ca2+-dependent shift of the kinase into a larger
protein complex (Hannan et al., 2003). Such data would be com-
patible with PI(3)P acting to recruit one ormore unknown FYVE or
PX domain-containing proteins to endosomes (Byfield et al.,
2005; Nobukuni et al., 2005), which is required to build
a mTOR Complex 1 signalosome. That hVps34 is part of such
a complex was unexpected; however, it has been shown that
small Rab GTPases recruit the hVps34/hVps15 complex to spe-
Figure 5. hVps34 Contains a Ca2+/CaM-Binding Motif
(A) Alignment of the hVps34 CaM-binding site in different species.
(B) Far western blotting of GST-hVps34 from AA-deprived or AA-stimulated
HEK293 cells with purified CaM in the presence of CaCl2 or EGTA (see Exper-
imental Procedures).
(C) HeLa cells were treated with AAs as in Figure 1A, and after 30 min, 1 mM
dithiobis(succinimidyl) propionate (DSP) was added for an additional 30 min
at 37C to either AA-deprived cells or 23 AA-stimulated cells with or without
W7 treatment, as in Figure 4A. Cells were then harvested, and hVps34 was
immunoprecipitated from lysates (see Experimental Procedures). Quantifica-
tion of western blots from three independent experiments (right panel) was
performed as in Figure 1B. Data are presented as mean ± SD.462 Cell Metabolism 7, 456–465, May 2008 ª2008 Elsevier Inc.cific cellular compartments, where FYVE or PX domain-contain-
ing proteins serve as Rab effectors (see Nobukuni et al., 2007). In
the studies presented here, we do not see an alteration in the
mTOR-hVps34 interaction as a function of AA stimulation, sug-
gesting that mTOR is recruited to the signalosome through its
interaction with hVps34. We would hypothesize that such an
interaction results in the described conformational change in
mTOR Complex 1, which allows Rheb-GTP to then interact
with mTOR (Long et al., 2005) and/or FKBP38 (Bai et al., 2007),
allowing activation of downstream effectors, such as S6K1
(Figure 7).
It was previously shown that autophagy, which is triggered by
AA withdrawal, also requires hVps34 and Ca2+ (Gordon et al.,
1993). However, in this case, the Ca2+ requirement was initially
proposed to be for the maintenance of high Ca2+ levels within
Figure 6. Ca2+/CaM Regulates hVps34 Lipid Kinase Activity
(A) HEK293 cells were transfected with vectors expressing wild-type (WT),
kinase-dead (KD), or CaM-binding mutants of hVps34 (see Experimental Pro-
cedures). Twenty-four hours posttransfection, cells were treated as in
Figure 1A, and cell lysates were then prepared and used to measure the
expression levels of each construct (upper panel) or for Ca2+/CaM-binding
assays (lower panel) as in Figure 4C.
(B) Equal amounts of WT, KD, and CaM-binding mutants of hVps34 expressed
in HEK293 cells, treated with AAs as in (A), were immunoprecipitated with an
anti-GST antibody, and lipid kinase assays were performed on the immuno-
complex in the presence of 0.5 mM CaCl2 as described previously (Nobukuni
et al., 2005).
(C) HEK293 cells were cotransfected with Myc-S6K1 and WT, KD, or CaM-
binding mutants of hVps34 and treated with AAs as in Figure 1A, and cell
lysates were then prepared and probed with the indicated antibodies.
(D) HEK293 cells were treated with AAs as in Figure 1A, and endogenous
hVps34 was immunoprecipitated from cell extracts in the presence of
0.5 mM CaCl2 or 2 mM EGTA. The resulting hVps34 immunoprecipitate was
then extensively washed in either 0.5 mM CaCl2 or 2 mM EGTA as in
Figure S4C. The hVps34 immunoprecipitates were assayed for lipid kinase
activity either directly, as in Figure 3D, or after the indicated additions (see
Experimental Procedures), as described previously (Nobukuni et al., 2005).
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AA stimulation leads to an increase in [Ca2+]i, which increases the interaction of Ca
2+/CaM with the inactive mTOR Complex 1 signalosome. Ca2+/CaM interacts
with hVps34 through its conserved CaM-binding motif, resulting in hVps34 activation, the production of PI(3)P, and a conformational change in the hVps34-as-
sociated mTOR Complex 1 signalosome. Increased PI(3)P would be predicted to recruit one or more unknown PX or FYVE-domain containing proteins, which
may also participate in generating the conformationally altered form of the mTOR Complex 1 signalosome. This conformational change is required for the dis-
placement of FKBP38 from the conformationally altered mTOR Complex 1 signalosome by insulin-induced Rheb-GTP. The model also indicates that Rheb-GTP
may independently drive activation of the mTOR Complex 1 signalosome through its reported direct interaction with mTOR (Long et al., 2005).the ER (Gordon et al., 1993), although a recent report suggests
that increased [Ca2+]i as well as depletion of Ca
2+ from the ER
triggers an autophagic response (Hoyer-Hansen et al., 2007).
In contrast to the effects on autophagy, which take days, AA-in-
duced activation of mTOR signaling occurs within minutes, with
no apparent requirement for the emptying of ER Ca2+ stores.
These observations are consistent with a potential role for
hVps34 in distinct functions of early endosome signaling versus
targeting of late endosomes to autophagic vesicles (Nobukuni
et al., 2005). Thismodel is compatible with studies in yeast where
at least two distinct Vps34 protein complexes have been identi-
fied (Kihara et al., 2001b) and the finding that whereas all cellular
beclin is associated with hVps34, 50% of hVps34 is beclin-free
(Kihara et al., 2001a). Consistent with these two distinct
hVps34 complexes, immunofluorescence microscopy has
shown that the beclin/hVps34 complex is localized to the
trans-Golgi network but the beclin-free hVps34 complex is local-
ized to endosomes (Kihara et al., 2001a). Thus, different hVps34
complexes maybe involved in regulating distinct responses,
such as endosome signaling and autophagy. Given the ability
of mTOR Complex 1 to drive cell growth and suppress autoph-
agy, it will be critical to identify the mechanisms by which these
two pathways interact at the cellular level.
In humans, it is known that circulating AAs are often elevated in
obese and insulin-resistant states (Um et al., 2006). Consistent
with these observations, it has been demonstrated in human
clamp studies that an approximate 2-fold rise in plasma AA con-
centrations is paralleled by a 25% reduction in insulin sensitivity
in skeletal muscle (Krebs, 2005). Moreover, the effects of AAs on
insulin resistance appear to be mediated by activation of mTOR
Complex 1 signaling followed by phosphorylation of IRS1 at sites
that antagonize insulin action (Tremblay et al., 2005b, 2007). The
importance of these observations extends beyond obesity and
insulin resistance, as a recent record-linked case-controlled
study showed that metformin, a widely prescribed antidiabetic
that increases insulin sensitivity and blunts mTOR Complex 1
signaling, reduces the risk of cancer in diabetic patients ina dose-dependent manner (Dann et al., 2007). With respect to
a potential role for Ca2+ in these pathologies, it is interesting to
note that in humans, increased skeletal muscle [Ca2+]i is associ-
ated with insulin resistance (Resnick, 1999). It will now be critical
to determine both the mechanism by which AAs cause a rise in
[Ca2+]i and the identity of the signalosome that mediates
mTOR Complex 1 activation. In summary, our findings point to
the importance of mTOR Complex 1 in insulin resistance and
cancer, potentially offering novel avenues to develop therapeutic
strategies.
EXPERIMENTAL PROCEDURES
Reagents
Rabbit anti-CaM and rabbit anti-hVps34 antibodies were from Invitrogen;
antibodies to mTOR, phospho-Thr389 S6K-1, phospho-Ser473 PKB, phos-
pho-Thr308 PKB, phospho-Ser65 4E-BP1, phospho-Thr37/46 4E-BP1, phos-
pho-44/42 Erk, PKB, phospho-Ser9 GSK3, and S6K1 were from Cell Signaling
Technologies; anti-GST antibodies were from Bethyl Laboratories; anti-PI(3)P
antibody was from Echelon; anti-tubulin antibody was from NeoMarkers; anti-
bodies to FRAP (N19) and c-Myc were from Santa Cruz Biotechnology; mouse
monoclonal anti-CaM and rabbit anti-raptor antibodies were from Upstate
Biotechnology; rabbit anti-hVps15 antibody was from Abgent; mouse mono-
clonal anti-beclin antibody was from Novus; and rabbit anti-Rheb antibody
was fromProSci. Pan anti-4E-BP1 antibodywas a kind gift fromN. Sonenberg.
Rabbit brain CaM was a gift from J. Dedman. Recombinant 4E-BP1 was from
AGScientific. BAPTA-AM,EGTA,W7,Tg, histamine, andwortmanninwere from
Calbiochem. Fluo-4 and Fura-2 were fromMolecular Probes. Dithiobis(succini-
midyl) propionate (DSP) and chemiluminescence kit were from Pierce. PreSci-
ssion protease, protein A and G Sepharose, and HRP-conjugated secondary
antibodies were from Amersham. All other reagents were from Sigma.
Cell Culture, Western Blotting, and Immunostaining
Maintenance of HeLa and HEK293 cells as well as AA deprivation, SDS-PAGE,
and immunostaining were performed as described previously (Nobukuni et al.,
2005), except that we have recently found that the response to either AA
withdrawal or addition works as well in dialyzed serum as in no serum.
Transfections and hVps34 CaM-Binding Site Mutagenesis
See Supplemental Experimental Procedures.Cell Metabolism 7, 456–465, May 2008 ª2008 Elsevier Inc. 463
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HeLa cell [Ca2+]i measurements were made directly on tissue culture plates, or
the cells were plated onto 25 mm round glass coverslips and then cultured for
24 to 48 hr prior to experimentation. Note that the high background autofluor-
escence of plastic necessitated the use of glass coverslips in the measure-
ment of Fura-2 fluorescence intensities. While the percentage of cells re-
sponding to AAs decreased when cells were cultured on glass (80% versus
25%–40%), similar [Ca2+]i response patterns were observed on both types
of substratum. Cells were loaded with Ca2+-sensitive indicator dyes during
the 2 hr AA-deprivation protocol. Cell loading was achieved by incubation
with the acetoxymethyl ester form of the dye (5 mM) and pluronic acid
(0.02% v/v) for 1 hr in serum- and AA-free DMEM. Cells were then washed
and transferred to a thermostatically regulated microscope chamber (37C).
Ca2+ imaging experimentswere performed in AA-free DMEMor aHEPES-buff-
ered physiological saline solution composed of (in mM) 25 HEPES (pH 7.4 at
37C), 121 NaCl, 5 NaHCO3, 4.7 KCl, 1.2 KH2PO4, 1.2 MgSO4, 2.0 CaCl2, 25
glucose, and 1 pyruvate. A 5% CO2/95% O2 atmosphere was maintained
above the microscope chamber when DMEM was used for Ca2+ measure-
ments. Fura-2 fluorescence images (excitation 340 and 380 nm, emission
420–600 nm) were acquired at 3 s intervals with a cooled charge-coupled de-
vice (CCD) camera as described previously (Rooney et al., 1989). [Ca2+]i values
were calculated from the 340/380 nm ratio after correcting for autofluores-
cence. Autofluorescence values were obtained at the end of each experiment
by permeabilizing the HeLa cells with digitonin in the presence of 2 mM EGTA.
The Fura-2 calibration parameters were determined as described previously
(Morgan and Thomas, 1999). Fluo-4 fluorescence intensity changes were de-
termined by confocal microscopy. The indicator was excited with the 488 nm
argon laser line, and emitted fluorescence was collected using a 515 nm
long-pass filter and manufacturer-supplied software.
Far Western Blot Analysis
GST-hVps34 was immunoprecipitated from cells and then blotted on a nitro-
cellulosemembrane. Themembranewas blocked for 30minwith 1%BSA pre-
pared in PBS with 0.1% Tween 20. The membrane was then incubated with
purified CaM (1 mg/ml) in the presence of either 0.5 mM CaCl2 or 2 mM
EGTA in the blocking buffer at 4C overnight. The next day, the membrane
waswashed three times (10min each) in PBSwith 0.1%Tween 20. Afterwards,
the membrane was immunostained with anti-CaM antibody. Membranes were
then stripped and probed with anti-hVps34 antibody.
Immunoprecipitation and Kinase Assays
GST-hVps34 was immunoprecipitated by adding 5 mg of goat anti-GST anti-
body (overnight at 4C) per 0.8–1.0 mg of protein lysate from cells transfected
with GST-hVps34 expression plasmid. Afterwards, 50 ml of a 50%slurry of pro-
tein G Sepharose beads was added, and incubation was continued for another
2 hr. The immunocomplex was further washed three times with lysis buffer as
described previously (Kim et al., 2002). Endogenous hVps34 was immunopre-
cipitated using 2.5 mg of anti-hVps34 antibody (anti-rabbit polyclonal antibody
generated in-house against a peptide corresponding to the 19 C-terminal res-
idues of hVps34). For hVps34 activity assays, immunoprecipitation was per-
formed in lysis buffer as described previously (Nobukuni et al., 2005), except
that the buffer contained 1 mM CaCl2 and 1 mM MgCl2 and the cell extracts
were incubated in the buffer for 20 min at 4C prior to centrifugation. The
hVps34 immunocomplex initial washes were performed as described previ-
ously (Nobukuni et al., 2005), except that (1) the final three washes in Tris-so-
dium-EDTA buffer were replaced by three 20min washes with EGTA, CaCl2, or
W7where indicated, and (2) all assays were performed in assay buffer contain-
ing 0.5 mMCaCl2, 10 mM Tris, and 100mMNaCl. In some samples, the higher
radioactivity at the origin was due to contaminating ATP from the aqueous
phase—i.e., when the capillary tube was passed through the radioactive
Sepharose A bead-containing interphase to recover the PI(3)P-containing
organic phase, some beads stuck to the tip of the capillary tube and were
loaded onto the thin-layer chromatography plate (Nobukuni et al., 2005). This
did not interfere with the chromatographic separation of PI(3)P.
mTOR immunoprecipitation, in vitro kinase activity assays, and S6K1 sub-
strate preparation were performed as described recently (Sancak et al.,
2007), except that mTOR was immunoprecipitated in the presence of464 Cell Metabolism 7, 456–465, May 2008 ª2008 Elsevier Inc.150 mM NaCl and during the preparation of S6K1 substrate, after removing
the affinity tag, S6K1 was purified on a glutathione agarose column.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and four
figures and can be found with this article online at http://www.
cellmetabolism.org/cgi/content/full/7/5/456/DC1/.
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